Contact this trialFirst, we need to learn more about you.
Immunotherapy
MK-6837 + Pembrolizumab for Cancer
Recruiting1 awardPhase 1
Morristown, New Jersey
This trial aims to test the safety, how well the drug is tolerated, how the drug moves through the body, and the initial effectiveness of MK-6837 alone and with pembrolizumab
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service